Trial Profile
Second pharmacokinetic study of ND0612
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 18 May 2017
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Pharmacokinetics
- 11 May 2017 According to a NeuroDerm media release, this trial initiation anticipated in the second half of 2017.
- 05 Apr 2017 New trial record